Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A retrospective, real world, the international, non-interventional study for efficacy and tolerability of Brivaracetam in patients

Next Previous
X
Search
Trial Profile

A retrospective, real world, the international, non-interventional study for efficacy and tolerability of Brivaracetam in patients

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Jun 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Brivaracetam (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms EXPERIENCE
  • Sponsors UCB Pharma Inc

    • Most Recent Events

    • 27 Apr 2023 Results (n=1644) assessing 12-month efficacy and safety of brivaracetam in highly drug-resistant cohorts, presented at the 75th Annual Meeting of the American Academy of Neurology 2023.
    • 06 Dec 2022 Results of subgroup analysis evaluating effectiveness and tolerability of brivaracetam (BRV) in pediatric patients in routine clinical practice presented at the 76th Annual Meeting of the American Epilepsy Society
    • 06 Dec 2022 Results of the international EXPERIENCE pooled analysis (n=1644) assessing the effectiveness and tolerability of Brivaracetam in patients with epilepsy, presented at the 76th Annual Meeting of the American Epilepsy Society.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top